Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1972 Aug;26(4):321–330. doi: 10.1038/bjc.1972.43

The Significance of Lymphocytic Infiltration in Neuroblastoma

I Lauder, W Aherne
PMCID: PMC2008644  PMID: 5071193

Abstract

A study of the significance of lymphocytic infiltration was made in a retrospective series of 23 primary neuroblastomata. The degree of lymphocytic infiltration was estimated and scored in 5 categories. Non-parametric rank order statistical methods were used to establish quantitative correlations, particularly with the duration of survival. A significant positive correlation was found both in infancy and childhood. It was found, unexpectedly, that the presence of metastases did not invalidate the correlation between lymphocyte score and survival.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERG J. W. Inflammation and prognosis in breast cancer; a search for host resistance. Cancer. 1959 Jul-Aug;12(4):714–720. doi: 10.1002/1097-0142(195907/08)12:4<714::aid-cncr2820120414>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  2. BLACK M. M., OPLER S. R., SPEER F. D. Structural representations of tumor-host relationships in gastric carcinoma. Surg Gynecol Obstet. 1956 May;102(5):599–603. [PubMed] [Google Scholar]
  3. Beckwith J. B., Martin R. F. Observations on the histopathology of neuroblastomas. J Pediatr Surg. 1968 Feb;3(1):106–110. doi: 10.1016/0022-3468(68)90989-5. [DOI] [PubMed] [Google Scholar]
  4. Bill A. H., Morgan A. Evidence for immune reactions to neuroblastoma and future possibilities for investigation. J Pediatr Surg. 1970 Apr;5(2):111–116. doi: 10.1016/0022-3468(70)90266-6. [DOI] [PubMed] [Google Scholar]
  5. Cowther D., Fairley G. H., Sewell R. L. Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J. 1969 May 24;2(5655):473–477. doi: 10.1136/bmj.2.5655.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cross R. M., Dixon F. W. A combined clinical and histological assessment of survival of patients with Hodgkin's disease. J Clin Pathol. 1971 Jul;24(5):385–393. doi: 10.1136/jcp.24.5.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crowther D., Fairley G. H., Sewell R. L. Lymphoid cellular responses in the blood after immunization in man. J Exp Med. 1969 May 1;129(5):849–869. doi: 10.1084/jem.129.5.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doll R., Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J. 1970 Nov 14;4(5732):420–422. doi: 10.1136/bmj.4.5732.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fairley G. H. Immunity to malignant disease in man. Br Med J. 1969 May 24;2(5655):467–473. doi: 10.1136/bmj.2.5655.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hamlin I. M. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer. 1968 Sep;22(3):383–401. doi: 10.1038/bjc.1968.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hellström I. E., Hellström K. E., Pierce G. E., Bill A. H. Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1231–1238. doi: 10.1073/pnas.60.4.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keast D. Immunosurveillance and cancer. Lancet. 1970 Oct 3;2(7675):710–712. doi: 10.1016/s0140-6736(70)91973-2. [DOI] [PubMed] [Google Scholar]
  13. Marshall W. H., Valentine F. T., Lawrence H. S. Cellular immunity in vitro. Clonal proliferation of antigen-stimulated lymphocytes. J Exp Med. 1969 Aug 1;130(2):327–343. doi: 10.1084/jem.130.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Martin R. F., Beckwith J. B. Lymphoid infiltrates in neuroblastomas: their occurrence and prognostic significance. J Pediatr Surg. 1968 Feb;3(1):161–164. doi: 10.1016/0022-3468(68)91005-1. [DOI] [PubMed] [Google Scholar]
  15. Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697–699. doi: 10.1016/s0140-6736(69)92648-8. [DOI] [PubMed] [Google Scholar]
  16. Osuntokun B. O., Monekosso G. L., Wilson J. Relationship of a degenerative tropical neuropathy to diet: report of a field survey. Br Med J. 1969 Mar 1;1(5643):547–550. doi: 10.1136/bmj.1.5643.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Piessens W. F. Evidence for human cancer immunity. A review. Cancer. 1970 Dec;26(6):1212–1220. doi: 10.1002/1097-0142(197012)26:6<1212::aid-cncr2820260606>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  18. STOWENS D. Neuroblastoma and related tumors. AMA Arch Pathol. 1957 May;63(5):451–459. [PubMed] [Google Scholar]
  19. Stewart T. H., Klassen D., Crook A. F. Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms. Can Med Assoc J. 1969 Aug 23;101(4):191–199. [PMC free article] [PubMed] [Google Scholar]
  20. Swan H. T., Knowelden J. Prognosis in Hodgkin's disease related to the lymphocyte count. Br J Haematol. 1971 Sep;21(3):343–349. doi: 10.1111/j.1365-2141.1971.tb03446.x. [DOI] [PubMed] [Google Scholar]
  21. Vánky F., Stjernswärd J., Nilsonne U. Cellular immunity to human sarcoma. J Natl Cancer Inst. 1971 Jun;46(6):1145–1151. [PubMed] [Google Scholar]
  22. YOON I. L. The eosinophil and gastrointestinal carcinoma. Am J Surg. 1959 Feb;97(2):195–200. doi: 10.1016/0002-9610(59)90432-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES